Retrospective Cohort Study of Novel Oral Agents Lenalidomide and Duvelisib For Relapsed or Refractory Mycosis Fungoides and Sézary Syndrome.

Autor: Elghawy O; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Yang AG; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Sussman JH; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Thomas CJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Carter JS; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kim E; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Rook AH; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Chung J; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Villasenor-Park J; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Plastaras JP; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia., LaRiviere M; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia., Hubbeling H; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia., Chelius M; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: stefan.barta@pennmedicine.upenn.edu.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Nov 16. Date of Electronic Publication: 2024 Nov 16.

CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas.

Autor: Cederquist GY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Schefflein J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY., Devlin SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Shah GL; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Shouval R; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Department of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Hubbeling H; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA., Tringale K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Radiation Medicine and Applied Sciences, UC San Diego, La Jolla, CA., Alarcon Tomas A; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Hematology and Hemotherapy Service, Hospital Universitario Gregorio Marañón, Madrid, Spain., Fregonese B; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Hajj C; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Boardman A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Luna De Abia A; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplantation Unit, Hospital Universitario Ramón y Cajal, Madrid, Spain., Corona M; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY., Cassanello G; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Dahi PB; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Lin RJ; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY., Ghione P; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Salles G; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Palomba ML; Department of Medicine, Weill Cornell Medical College, New York, NY.; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Falchi L; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Scordo M; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY., Grommes C; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY., Yahalom J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Imber BS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: Blood advances [Blood Adv] 2024 Oct 08; Vol. 8 (19), pp. 5192-5199.

Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphoma.

Autor: Jiang C; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kim M; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Han X; Department of Biostatics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Chelius M; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Hoover T; Department of Radiation Oncology, University of Maryland, Baltimore, Maryland, USA., Kersun L; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Reilly AF; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Hubbeling H; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Cummings E; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kurtz G; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Hill-Kayser C; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Plastaras JP; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., LaRiviere MJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Dec; Vol. 71 (12), pp. e31290. Date of Electronic Publication: 2024 Sep 12.

Conventional and novel [ ¹⁸ F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma.

Autor: Leithner D; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.; Department of Radiology, NYU Grossman School of Medicine, New York, USA., Flynn JR; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Devlin SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mauguen A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fei T; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zeng S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zheng J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Imber BS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hubbeling H; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mayerhoefer ME; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.; Department of Radiology, NYU Grossman School of Medicine, New York, USA.; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria., Bedmutha A; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA., Luttwak E; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Corona M; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, 530 E74th Street, NY, 10021, New York, USA.; Hematology and Hemotherapy Service, Hospital Universitario 12 de Octubre, Madrid, Spain., Dahi PB; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, 530 E74th Street, NY, 10021, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Luna de Abia A; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, 530 E74th Street, NY, 10021, New York, USA.; Bone Marrow Transplantation Unit, Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain., Landego I; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, 530 E74th Street, NY, 10021, New York, USA., Lin RJ; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, 530 E74th Street, NY, 10021, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Palomba ML; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Scordo M; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, 530 E74th Street, NY, 10021, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Park JH; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tomas AA; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, 530 E74th Street, NY, 10021, New York, USA.; Department of Hematology, Hospital Universitario Puerta de Hierro, Madrid, Spain., Salles G; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Lafontaine D; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA., Michaud L; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.; Department of Nuclear Medicine and Molecular ImagingLausanne University Hospital (CHUV), Lausanne, Switzerland., Shah GL; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, 530 E74th Street, NY, 10021, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Perales MA; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, 530 E74th Street, NY, 10021, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Shouval R; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, 530 E74th Street, NY, 10021, New York, USA. shouvalr@mskcc.org.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. shouvalr@mskcc.org., Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.

Publikováno v: Journal of hematology & oncology [J Hematol Oncol] 2024 Apr 23; Vol. 17 (1), pp. 21. Date of Electronic Publication: 2024 Apr 23.

HUBBELING, H. G., Spinoza, Herder, Barcelona, 1981, 161 págs. [RECENSIÓN]

Autor: Cruz-Cruz, J. (Juan)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1111::93efee70e299d911f4369ae4534e90df
https://hdl.handle.net/10171/54903